Evidence map›Paper›PMID 26495421›Full record

ArticleTheScientificWorldJournal2015

Using Bioinformatics Approach to Explore the Pharmacological Mechanisms of Multiple Ingredients in Shuang-Huang-Lian.

Bai-xia Zhang, Jian Li, Hao Gu, Qiang Li, Qi Zhang, Tian-jiao Zhang, Yun Wang, Cheng-ke Cai

Abstract read
In one paragraph

Article in TheScientificWorldJournal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Bai-xia ZhangSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100102, China.
Jian LiSchool of Basic Medical Sciences, Beijing University of Chinese Medicine, Beijing 100029, China.
Hao GuInstitute of Basic Research of Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Qiang LiSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100102, China.
Qi ZhangSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100102, China.
Tian-jiao ZhangSchool of Basic Medical Sciences, Beijing University of Chinese Medicine, Beijing 100029, China.
Yun WangSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100102, China.
Cheng-ke CaiSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100102, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to the proved clinical efficacy, Shuang-Huang-Lian (SHL) has developed a variety of dosage forms. However, the in-depth research on targets and pharmacological mechanisms of SHL preparations was scarce. In the presented study, the bioinformatics approaches were adopted to integrate relevant data and biological information. As a result, a PPI network was built and the common topological parameters were characterized. The results suggested that the PPI network of SHL exhibited a scale-free property and modular architecture. The drug target network of SHL was structured with 21 functional modules. According to certain modules and pharmacological effects distribution, an antitumor effect and potential drug targets were predicted. A biological network which contained 26 subnetworks was constructed to elucidate the antipneumonia mechanism of SHL. We also extracted the subnetwork to explicitly display the pathway where one effective component acts on the pneumonia related targets. In conclusions, a bioinformatics approach was established for exploring the drug targets, pharmacological activity distribution, effective components of SHL, and its mechanism of antipneumonia. Above all, we identified the effective components and disclosed the mechanism of SHL from the view of system.

Indexed as

Computational BiologyDrugs, Chinese HerbalFlavonesFlavonoidsGlucosidesHumansLuteolinMetabolic Networks and PathwaysPneumoniaProtein Interaction MapsdihydrooroxylinDrugs, Chinese HerbalFlavonesFlavonoidsGlucosidesLuteolinluteolin-7-glucosideshuang-huang-lian

Identifiers

PMID26495421
PMCPMC4606080

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.